Cell Medica

Cell Medica

Cell Medica

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer.
Founded
2006
Raised
$192.1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$78,382,191
Venture capital (Series B) - 2014
Woodford Investment Management Invesco Perpetual
Team Size
1–10
Employees
$74,100,000 Venture capital (Series C)
PE HUB

Cell Medica pulls in about $74.1 mln Series C

Funding
FinSMEs

Cell Medica Closes £60M Series C Funding

Funding Health Science